Changing microbiology of pediatric neck abscesses in iowa 2000-2010

Laryngoscope

Volumn 123, Issue 1, 2013, Pages 249-252

  Walker, Paul C ^a   Karnell, Lucy Hynds ^a   Ziebold, Christine ^b   Kacmarynski, Deborah S F ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

Author keywords

abscess; antibiotics; infections; Level of Evidence: 4; MRSA; otolaryngology; Pediatrics

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINEZOLID; STEROID; SULTAMICILLIN; VANCOMYCIN;

ABSCESS; ABSCESS DRAINAGE; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; FEMALE; HEAD AND NECK DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MOUTH FLORA; NECK ABSCESS; PEDIATRICS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TERTIARY HEALTH CARE;

ABSCESS; ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; DRAINAGE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; INFANT; IOWA; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NECK; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84871720681     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23500     Document Type: Article

References (24)

1. Buescher ES,. Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics. Curr Opin Pediatr 2005; 17: 67-70.
2. Creel AM, Durham SH, Benner KW, Alten JA, Winkler MK,. Severe invasive community-associated methicillin-resistant Staphylococcus aureus infections in previously healthy children. Pediatr Crit Care Med 2009; 10: 323-327.
3. Crum NF, Lee RU, Thornton SA, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006; 119: 943-951.
4. Guss J, Kazahaya K,. Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses. Int J Pediatr Otorhinolaryngol 2007; 71: 943-948.
5. Inman JC, Rowe M, Ghostine M, Fleck T,. Pediatric neck abscesses: changing organisms and empiric therapies. Laryngoscope 2008; 118: 2111-2114.
6. Naidu SI, Donepudi SK, Stocks RM, Buckingham SC, Thompson JW,. Methicillin-resistant Staphylococcus aureus as a pathogen in deep neck abscesses: a pediatric case series. Int J Pediatr Otorhinolaryngol 2005; 69: 1367-1371.
7. Ossowski K, Chun RH, Suskind D, Baroody FM,. Increased isolation of methicillin-resistant Staphylococcus aureus in pediatric head and neck abscesses. Arch Otolaryngol Head Neck Surg 2006; 132: 1176-1181.
8. Thomason TS, Brenski A, McClay J, Ehmer D,. The rising incidence of methicillin-resistant Staphylococcus aureus in pediatric neck abscesses. Otolaryngol Head Neck Surg 2007; 137: 459-464.
9. Jorgensen JH, Crawford SA, McElmeel ML, Fiebelkorn KR,. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J Clin Microbiol 2004; 42: 1800-1802.
10. Dietrich DW, Auld DB, Mermel LA,. Community-acquired methicillin- resistant Staphylococcus aureus in southern New England children. Pediatrics 2004; 113: e347-52.
11. Chen AE, Goldstein M, Carroll K, Song X, Perl TM, Siberry GK,. Evolving epidemiology of pediatric Staphylococcus aureus cutaneous infections in a Baltimore hospital. Pediatr Emerg Care 2006; 22: 717-723.
12. Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21: 530-534.
13. Seal J, Glynn L, Statter M, Liu D,. A high prevalence of methicillin-resistant Staphylococcus aureus among surgically drained soft-tissue infections in pediatric patients. Pediatr Surg Int 2006; 22: 683-687.
14. Pickett A, Wilkinson M, Menoch M, Snell J, Yniguez R, Bulloch B,. Changing incidence of methicillin-resistant Staphylococcus aureus skin abscesses in a pediatric emergency department. Pediatr Emerg Care 2009; 25: 831-834.
15. Gemmell CG,. Antibiotics and the expression of staphylococcal virulence. J Antimicrob Chemother 1995; 36: 283-291.
16. Herigon JC, Hersh AL, Gerber JS, Zaoutis TE, Newland JG,. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008 Pediatrics 2010; 125: e1294-300.
17. Magilner D, Byerly MM, Cline DM,. The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department. N C Med J 2008; 69: 351-354.
18. Shapiro A, Raman S, Johnson M, Piehl M,. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors. N C Med J 2009; 70: 102-107.
19. Szczesiul JM, Shermock KM, Murtaza UI, Siberry GK,. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections. Pediatr Infect Dis J 2007; 26: 852-854.
20. Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P,. Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev 2007; 20: 79-114.
21. Levin TP, Suh B, Axelrod P, Truant AL, Fekete T,. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother 2005; 49: 1222-1224.
22. Lewis JS, 2nd, Jorgensen JH,. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005; 40: 280-285.
23. Siberry GK, Tekle T, Carroll K, Dick J,. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003; 37: 1257-1260.
24. Martinez-Aguilar G, Hammerman WA, Mason EO, Jr, Kaplan SL,. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003; 22: 593-598.